That Rubbish, we not know what “all regulatory agencies” have said for viraleze classification. All we know is few regulatory agencies: Vietnam, India, UK, EMA, NZ, Saudi have medical device listing/NB conformity for viraleze and some not allow covid label claims. SH know nothing about all other regulatory body’s.
We not even know what happens in India that no license or launch. Is it a problem with voluntary device listing by SPL with no regulatory review ? remember in Japan with condom after 1st approval in 2014, but then tangled up and reclassified to correct class and 1st launch in 2019. overpaid jacky and Paull do it again.
something has to give.....the share price is absolutely ridiculous, page-27
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.90M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $38.11K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20455 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 38876 | 3 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |